XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.3
License and Collaboration Agreements (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2022
Research and License Agreements      
Revenue from collaboration and license agreements     $ 75,000
Apollomics, Inc.      
Research and License Agreements      
Up-front payment received   $ 9,000,000.0  
Milestones based on achievement of certain clinical and regulatory events   75,000,000.0  
Milestone payment upon achievement of specified net sales thresholds for all licensed products   $ 105,000,000.0  
Milestone revenue recognized based on achievement of certain clinical and regulatory events $ 1,000,000.0    
Apollomics, Inc. | Maximum      
Research and License Agreements      
Tiered percentage of annual net sales   15.00%